This new position paper proposes 5 pre-defined business priorities to help pharma affiliates adjust to the changes of HCPs expectations, so that to keep them engaged in the post-Covid-19 era.
News
Smart Pharma Consulting has analyzed in this new position paper the major implications for pharma companies of...
Global Pharma R&D has reached an unprecedented level in extending patients’ life and improving their quality of...
This new position paper analyses: